{"schema_version":"secwatch.filing_event.v1","accession":"0001005286-24-000081","form_type":"8-K","ticker":"LFCR","cik":"0001005286","company_name":"LIFECORE BIOMEDICAL, INC. DE","filed_at":"2024-07-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.848322+00:00","generated_at":"2026-05-31T23:53:11.466154+00:00","sec_items":["1.01","5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Lifecore settles proxy fight with 22NW, adds four new directors and declassification proposal","bullets":["22NW withdraws director nominations and special meeting demand; board declassification proposal at 2023 annual meeting.","Four new directors appointed: Humberto Antunes, Jason Aryeh, Paul Johnson, Matthew Korenberg.","Standstill agreements with 22NW, Legion, Wynnefield through 2025 annual meeting.","Board size to reduce to 8 pre-AGM, expand to 11 post-AGM, then back to 9 by Nov 2024.","Three investor groups collectively own ~43.5% of voting securities on as-converted basis."],"urls":{"canonical":"https://secwatch.observer/filing/0001005286-24-000081","json":"https://secwatch.observer/filing/0001005286-24-000081.json","markdown":"https://secwatch.observer/filing/0001005286-24-000081.md","text":"https://secwatch.observer/filing/0001005286-24-000081.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1005286/000100528624000081/0001005286-24-000081-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1005286/000100528624000081/lndc-20240628.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T23:53:11.466154+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0e1d2da00b","claim":"Humberto C. Antunes was appointed as Director at LIFECORE BIOMEDICAL, INC. DE.","evidence_excerpt":"On June 28, 2024, pursuant to the 22NW Cooperation Agreement, the Board, upon the recommendation of the Nominating Committee, appointed Paul H. Johnson, Humberto C. Antunes, and Matthew Korenberg as directors, effective immediately following the conclusion of the 2023 Annual Meeting.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1005286/000100528624000081/0001005286-24-000081-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"5287d4d52f","claim":"Paul H. Johnson was appointed as Director at LIFECORE BIOMEDICAL, INC. DE.","evidence_excerpt":"On June 28, 2024, pursuant to the 22NW Cooperation Agreement, the Board, upon the recommendation of the Nominating Committee, appointed Paul H. Johnson, Humberto C. Antunes, and Matthew Korenberg as directors, effective immediately following the conclusion of the 2023 Annual Meeting.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1005286/000100528624000081/0001005286-24-000081-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"eeb6b037f7","claim":"Matthew Korenberg was appointed as Director at LIFECORE BIOMEDICAL, INC. DE.","evidence_excerpt":"On June 28, 2024, pursuant to the 22NW Cooperation Agreement, the Board, upon the recommendation of the Nominating Committee, appointed Paul H. Johnson, Humberto C. Antunes, and Matthew Korenberg as directors, effective immediately following the conclusion of the 2023 Annual Meeting.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1005286/000100528624000081/0001005286-24-000081-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}